Related Experiment Video
Updated: Jul 10, 2026
16:56
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Sublingual immunization induces broad-based systemic and mucosal immune responses in mice
Nicolas Cuburu1, Mi-Na Kweon, Joo-Hye Song
1Institut National de la Santé et de la Recherche Médicale (INSERM), Unité Mixte de Recherche (UMR) 721, Université de Nice-Sophia Antipolis, Nice, France.
Vaccine
|November 13, 2007
Summary
Sublingual vaccine delivery in mice shows potential. This method effectively stimulates systemic and mucosal immunity, comparable to intranasal delivery, offering a promising alternative route for vaccines.
Area of Science:
- Immunology
- Vaccinology
- Mucosal Immunity
Background:
- The sublingual (s.l.) mucosa presents a potential site for vaccine delivery due to its rich immune cell network.
- Understanding the immune response kinetics following s.l. administration is crucial for vaccine development.
Purpose of the Study:
- To evaluate the efficacy of sublingual vaccine delivery in a murine model.
- To characterize the immune responses induced by s.l. immunization.
Main Methods:
- Mice were immunized sublingually with ovalbumin and cholera toxin (CT) adjuvant.
- Immune responses were assessed by measuring antibody titers, cytokine profiles, and cytotoxic T cell activity.
- Influenza virus challenge was used to evaluate safety and efficacy.
Main Results:
- Sublingual immunization with ovalbumin and CT induced robust systemic and mucosal antibody responses.
- This method promoted mixed Th1/Th2 cytokine profiles and cytotoxic CD8(+) T cell induction.
- Sublingual delivery was comparable to intranasal and superior to oral immunization in terms of immune response magnitude and dissemination.
- Sublingual administration of live influenza virus was well-tolerated and safe.
Conclusions:
- The sublingual mucosa serves as an effective route for vaccine delivery, inducing significant systemic and mucosal immunity.
- Sublingual immunization offers advantages over oral delivery and is comparable to intranasal delivery.
- This approach holds promise as an alternative vaccine administration strategy.
